Validation of the PLASMIC score at a University Medical Center

Ryan Jajosky, Mark Floyd, Thomas Thompson, James F Shikle

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background The PLASMIC score was recently described as a convenient tool for predicting ADAMTS13 activity ≤10% in patients with possible thrombotic thrombocytopenic purpura (TTP), while awaiting the results of this send-out test. The purpose of this study was to validate the PLASMIC score at our University Medical Center. Methods Apheresis records were reviewed from 2008 to 2017 to identify patients who received plasma exchange (PLEX) for suspected TTP. The ADAMTS13 activity and PLASMIC scoring criteria were recorded, and the PLASMIC score was calculated. Results Of the 41 patients identified, 20 met inclusion criteria, of which 7 patients had ADAMTS13 activity ≤10%. Intermediate and high PLASMIC scores had 100% sensitivity, 46.2% specificity, 50% positive predictive value (PPV), and 100% negative predictive value (NPV). Conclusion These results are consistent with the original validation study of the PLASMIC score, supporting the efficacy of the PLASMIC score and validating its use at our institution.

Original languageEnglish (US)
Pages (from-to)591-594
Number of pages4
JournalTransfusion and Apheresis Science
Volume56
Issue number4
DOIs
StatePublished - Aug 1 2017

Fingerprint

Thrombotic Thrombocytopenic Purpura
Blood Component Removal
Plasma Exchange
Validation Studies
Sensitivity and Specificity

Keywords

  • ADAMTS13 activity
  • Plasma exchange (PLEX)
  • Thrombotic microangiopathy (TMA)

ASJC Scopus subject areas

  • Hematology

Cite this

Validation of the PLASMIC score at a University Medical Center. / Jajosky, Ryan; Floyd, Mark; Thompson, Thomas; Shikle, James F.

In: Transfusion and Apheresis Science, Vol. 56, No. 4, 01.08.2017, p. 591-594.

Research output: Contribution to journalArticle

Jajosky, Ryan ; Floyd, Mark ; Thompson, Thomas ; Shikle, James F. / Validation of the PLASMIC score at a University Medical Center. In: Transfusion and Apheresis Science. 2017 ; Vol. 56, No. 4. pp. 591-594.
@article{7a435697f1b444c68477c7df0d36ccd1,
title = "Validation of the PLASMIC score at a University Medical Center",
abstract = "Background The PLASMIC score was recently described as a convenient tool for predicting ADAMTS13 activity ≤10{\%} in patients with possible thrombotic thrombocytopenic purpura (TTP), while awaiting the results of this send-out test. The purpose of this study was to validate the PLASMIC score at our University Medical Center. Methods Apheresis records were reviewed from 2008 to 2017 to identify patients who received plasma exchange (PLEX) for suspected TTP. The ADAMTS13 activity and PLASMIC scoring criteria were recorded, and the PLASMIC score was calculated. Results Of the 41 patients identified, 20 met inclusion criteria, of which 7 patients had ADAMTS13 activity ≤10{\%}. Intermediate and high PLASMIC scores had 100{\%} sensitivity, 46.2{\%} specificity, 50{\%} positive predictive value (PPV), and 100{\%} negative predictive value (NPV). Conclusion These results are consistent with the original validation study of the PLASMIC score, supporting the efficacy of the PLASMIC score and validating its use at our institution.",
keywords = "ADAMTS13 activity, Plasma exchange (PLEX), Thrombotic microangiopathy (TMA)",
author = "Ryan Jajosky and Mark Floyd and Thomas Thompson and Shikle, {James F}",
year = "2017",
month = "8",
day = "1",
doi = "10.1016/j.transci.2017.06.006",
language = "English (US)",
volume = "56",
pages = "591--594",
journal = "Transfusion and Apheresis Science",
issn = "1473-0502",
publisher = "Elsevier Limited",
number = "4",

}

TY - JOUR

T1 - Validation of the PLASMIC score at a University Medical Center

AU - Jajosky, Ryan

AU - Floyd, Mark

AU - Thompson, Thomas

AU - Shikle, James F

PY - 2017/8/1

Y1 - 2017/8/1

N2 - Background The PLASMIC score was recently described as a convenient tool for predicting ADAMTS13 activity ≤10% in patients with possible thrombotic thrombocytopenic purpura (TTP), while awaiting the results of this send-out test. The purpose of this study was to validate the PLASMIC score at our University Medical Center. Methods Apheresis records were reviewed from 2008 to 2017 to identify patients who received plasma exchange (PLEX) for suspected TTP. The ADAMTS13 activity and PLASMIC scoring criteria were recorded, and the PLASMIC score was calculated. Results Of the 41 patients identified, 20 met inclusion criteria, of which 7 patients had ADAMTS13 activity ≤10%. Intermediate and high PLASMIC scores had 100% sensitivity, 46.2% specificity, 50% positive predictive value (PPV), and 100% negative predictive value (NPV). Conclusion These results are consistent with the original validation study of the PLASMIC score, supporting the efficacy of the PLASMIC score and validating its use at our institution.

AB - Background The PLASMIC score was recently described as a convenient tool for predicting ADAMTS13 activity ≤10% in patients with possible thrombotic thrombocytopenic purpura (TTP), while awaiting the results of this send-out test. The purpose of this study was to validate the PLASMIC score at our University Medical Center. Methods Apheresis records were reviewed from 2008 to 2017 to identify patients who received plasma exchange (PLEX) for suspected TTP. The ADAMTS13 activity and PLASMIC scoring criteria were recorded, and the PLASMIC score was calculated. Results Of the 41 patients identified, 20 met inclusion criteria, of which 7 patients had ADAMTS13 activity ≤10%. Intermediate and high PLASMIC scores had 100% sensitivity, 46.2% specificity, 50% positive predictive value (PPV), and 100% negative predictive value (NPV). Conclusion These results are consistent with the original validation study of the PLASMIC score, supporting the efficacy of the PLASMIC score and validating its use at our institution.

KW - ADAMTS13 activity

KW - Plasma exchange (PLEX)

KW - Thrombotic microangiopathy (TMA)

UR - http://www.scopus.com/inward/record.url?scp=85026489102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026489102&partnerID=8YFLogxK

U2 - 10.1016/j.transci.2017.06.006

DO - 10.1016/j.transci.2017.06.006

M3 - Article

C2 - 28764998

AN - SCOPUS:85026489102

VL - 56

SP - 591

EP - 594

JO - Transfusion and Apheresis Science

JF - Transfusion and Apheresis Science

SN - 1473-0502

IS - 4

ER -